The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve physical functioning following weight loss, according to the results of a recent clinical trial by Novo Nordisk,

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As weight loss medications like Ozempic continue to gain traction for their positive impact on various health issues,

“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, which addresses the physical link between obesity and osteoarthritis, but it may also help to tamp down on bodily inflammation, Dr. Mandelbaum says.

Recent research has found that semaglutide injections, which also include controversial weight loss drug Ozempic, can reduce knee pain caused by obesity-related arthritis.

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain